Physician profile
Ashley E Ebert
NPI 1346638806
$597.23
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.51 · 2022: $287 · 2023: $204 · 2024: $50.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $253.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $111.80 | 2022-2024 | Rexulti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $71.69 | 2022 | |
| Genentech USA, INC. | $56.51 | 2021 | |
| Axsome Therapeutics, INC. | $48.45 | 2023 | Auvelity |
| Astrazeneca Pharmaceuticals Lp | $42.07 | 2022-2023 | Farxiga |
| Lundbeck LLC | $39.99 | 2022 | |
| Neurocrine Biosciences, INC. | $36.54 | 2022-2023 | Ingrezza |
| Abbvie INC. | $28.79 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $26.76 | 2022-2023 | Quviviq |
| Novartis Pharmaceuticals Corporation | $23.90 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $23.01 | 2023 | Trintellix |
| Almatica Pharma LLC | $17.04 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.39 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.77 | 2022 | |
| Exact Sciences Corporation | $13.86 | 2023 | Cologuard Collection Kit |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $13.29 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $12.37 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Ebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.